{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T10:43:27Z","timestamp":1648982607629},"reference-count":0,"publisher":"Portland Press Ltd.","issue":"5","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1990,10,1]]},"abstract":"<jats:p>Summary<\/jats:p>\n               <jats:p>Serum levels of keratan sulphate (KS) were found to be significantly elevated in patients with destructive and predominantly seronegative rheumatoid arthritis (RA) compared with a control population. Levels in RA did not correlate with clinical or laboratory indices of joint activity or damage. Conversely levels were depressed in ankylosing spondylitis (AS) compared with controls.<\/jats:p>","DOI":"10.1042\/bst0180964","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T12:28:05Z","timestamp":1439296085000},"page":"964-965","update-policy":"http:\/\/dx.doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum keratan sulphate levels rise in rheumatoid arthritis patients, but fall in ankylosing spondylitis patients compared with normal controls"],"prefix":"10.1042","volume":"18","author":[{"given":"ROB","family":"WILL","sequence":"first","affiliation":[{"name":"Royal National Hospital for Rheumatic Diseases, Bath BA1 1RL, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUDITH","family":"ELSWOOD","sequence":"additional","affiliation":[{"name":"Royal National Hospital for Rheumatic Diseases, Bath BA1 1RL, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LAUREL","family":"EDMUNDS","sequence":"additional","affiliation":[{"name":"Royal National Hospital for Rheumatic Diseases, Bath BA1 1RL, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANDREI","family":"CALIN","sequence":"additional","affiliation":[{"name":"Royal National Hospital for Rheumatic Diseases, Bath BA1 1RL, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/18\/5\/964\/521765\/bst0180964.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/18\/5\/964\/521765\/bst0180964.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T23:22:52Z","timestamp":1637277772000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/18\/5\/964\/84325\/Serum-keratan-sulphate-levels-rise-in-rheumatoid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,10,1]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,10,1]]}},"URL":"https:\/\/doi.org\/10.1042\/bst0180964","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,10,1]]}}}